NIH Reporter #CX-23-023

Examining ketamine effects on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease

A VA-funded randomized, placebo-controlled study investigating intravenous ketamine's effects on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease to explore its treatment potential.

Description

This project involves a randomized, placebo-controlled study to examine the effects of intravenous ketamine on depression, neuroplasticity, and inflammation in Veterans with Parkinson's disease. The study aims to understand ketamine's mechanisms of action and its potential as a treatment, with a focus on neuroplasticity and inflammatory markers. The project is funded by the VA and aligns with VA priorities to improve outcomes for Veterans with neuropsychiatric disorders.

View original record